Markus Dietlein
-
- Medical Imaging Techniques and Applications 59
- Radiopharmaceutical Chemistry and Applications 47
- Radiomics and Machine Learning in Medical Imaging 25
-
- Thyroid Cancer Diagnosis and Treatment 88
- Thyroid Disorders and Treatments 35
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 70
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 60
- Neurology top 1%
-
- Thyroid and Parathyroid Surgery 29
- Co-authors
- H SchichaCarsten KobeMarkus LusterKlemens ScheidhauerMatthias SchmidtAlexander DrzezgaMichael LaßmannDetlef Moka
- Cited by
- Radiology, Nuclear Medicine and ImagingEndocrinology, Diabetes and MetabolismPathology and Forensic Medicine
- Journals
- Nuklearmedizin - NuclearMedicine (68 papers)European Journal of Nuclear Medicine and Molecular Imaging (21 papers)Blood (20 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Markus Dietlein
259 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Radiology, Nuclear Medicine and Imaging 3.4k
- Endocrinology, Diabetes and Metabolism 2.1k
- Pathology and Forensic Medicine 1.9k
- Pulmonary and Respiratory Medicine 2.4k
- Neurology 846
Countries citing papers authored by Markus Dietlein
This map shows the geographic impact of Markus Dietlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Dietlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Dietlein more than expected).
Fields of papers citing papers by Markus Dietlein
This network shows the impact of papers produced by Markus Dietlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Dietlein. The network helps show where Markus Dietlein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus Dietlein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 9 | |
| 6 | 2019 | 2 | |
| 7 | [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4]. | 2016 | 19 |
| 8 | Radioiodtherapie bei benignen Schilddrüsenerkrankungen (Version 5)*: DGN-Handlungsempfehlung (S1-Leitlinie) | 2016 | 2 |
| 9 | Calcitonin-Screening bei Patienten mit Schilddrüsenknoten – Diagnostische Bedeutung | 2012 | 4 |
| 10 | 2011 | 60 | |
| 11 | Vorbehalte der DGN zur Nutzenbewertung der PET durch das IQWiG | 2010 | 7 |
| 12 | Rekombinantes humanes TSH im Vergleich zur Hypothyreose | 2010 | 12 |
| 13 | Adipositas, Stoffwechsel und Schilddrüse Ist der grenzwertig hohe TSH-Spiegel Ursache oder Sekundärphänomen der Adipositas? | 2008 | 9 |
| 14 | Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphomabreakdown → | 2007 | 967 |
| 15 | 2004 | 11 | |
| 16 | [PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer]. | 2003 | 14 |
| 17 | [18F-Fluorodeoxyglucose positron emission tomography in restaging of colorectal cancer]. | 2003 | 4 |
| 18 | [Cost-effectiveness of PET in the management algorithms of lung tumors: comparison of health economic data]. | 2001 | 4 |
| 19 | [Quality criteria for cost-benefit analysis in oncologic nuclear medicine and state of its realization]. | 1999 | 0 |
| 20 | Cost-effectiveness-analysis: Radioiodine or Antithyroid Drugs as First-line Therapy of Hyperthyroidism due to Graves' Disease | 1999 | 3 |
About Markus Dietlein
Markus Dietlein is a scholar working on Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 280 papers that have together received 7.1k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (88 papers), Lymphoma Diagnosis and Treatment (70 papers), Lung Cancer Treatments and Mutations (60 papers), Medical Imaging Techniques and Applications (59 papers), Radiopharmaceutical Chemistry and Applications (47 papers), Thyroid Disorders and Treatments (35 papers), Thyroid and Parathyroid Surgery (29 papers) and Radiomics and Machine Learning in Medical Imaging (25 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (3.4k citations), Endocrinology, Diabetes and Metabolism (2.1k citations) and Pathology and Forensic Medicine (1.9k citations). Markus Dietlein has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include H Schicha, Carsten Kobe, Markus Luster, Klemens Scheidhauer, Matthias Schmidt, Alexander Drzezga, Michael Laßmann, Detlef Moka, P. Theissen and Bernd Neumaier. Their work appears in journals such as Nuklearmedizin - NuclearMedicine, European Journal of Nuclear Medicine and Molecular Imaging, Blood, Journal of Clinical Oncology and Journal of Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.